SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zura Bio Ltd. is a clinical-stage biotechnology company, which engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded by Someit Sidhu on January 18, 2022 and is headquartered in Henderson, NV.

Zura Bio Ltd - Ordinary Shares - Class A

Zura Bio is seeing increased trading activity following a public offering of Class A Ordinary Shares that has tightened supply and stabilized its price action. Investors are closely monitoring the stock for a potential momentum push as they look past the recent dilution toward upcoming Phase 2 clinical trial readouts for its lead autoimmune drug, Tibulizumab.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is facing significant market pressure as investors digest conservative long-term revenue guidance and the looming expiration of the TDAPA reimbursement period, despite ongoing share buybacks and institutional accumulation. The community is sharply divided, with some actively debating the long-term potential of the DefenCath product line and Rezzayo clinical trial results, while others express frustration over management's communication and the stock's persistent volatility.

TOSHI

TOSHI is currently seeing intense community activity as investors debate the potential for a bullish breakout, with many focusing on accumulation strategies despite recent volatility. Supporters are pointing to positive technical indicators and rumors of major exchange listings as catalysts, while others emphasize the coin's role within the Base ecosystem and its long-term potential compared to broader market trends.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

Vanguard S&P 500 ETF (VOO) is trending as retail investors engage in intense debate over whether to "buy the dip" amidst market volatility, geopolitical tensions in the Middle East, and concerns about potential economic cooling. The community is actively discussing diverse strategies ranging from long-term dollar-cost averaging to tactical hedging, all while reacting to conflicting macroeconomic signals and broader market uncertainty.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is trending as investors react to a significant binding agreement with Yotta Data Services to deploy high-performance GPU infrastructure in India, sparking intense debate over whether the company’s pipeline and recent contract wins finally justify its current valuation. While the community is split between bullish sentiment regarding the company’s growth potential and skepticism over transparency, communication strategies, and the pace of execution, the stock remains a focal point for traders tracking potential short squeeze dynamics due to its compressed price and tight float.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is currently trending as investors weigh significant shifts in its EV strategy, specifically the focus on a new affordable $30,000 midsize electric pickup platform following a $19.5 billion write-down on previous EV efforts. The community is actively debating the company's long-term profitability, the impact of recent software recalls, and how these internal pivots align with broader sector challenges regarding hybrid versus pure-electric transitions.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna Inc. is seeing intense investor focus as rising geopolitical tensions in the Middle East and concerns over natural gas supply constraints in Europe drive demand for the companys microgrid energy assets. The community is actively discussing the stock's potential for a short squeeze due to high cost-to-borrow fees and limited share availability, with many traders drawing parallels to other volatile energy plays and monitoring warrants for leveraged upside.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is currently experiencing significant downward pressure as investors react to mixed earnings results and uncertainty surrounding future steel tariff policies. The decline has been intensified by reports of major insider share sales, fueling bearish sentiment and active debate within the community regarding management's long-term strategy and the status of the highly anticipated POSCO partnership.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with mobility drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, and taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting carriers with shippers on its platform, and gives carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is experiencing significant market interest following a strategic multi-year partnership with Amazon's Zoox to integrate purpose-built robotaxis into its ride-hailing platform. While the stock continues to navigate volatility driven by broader macro concerns and intense competition in the autonomous vehicle sector, community sentiment remains sharply divided between those viewing the company as a key infrastructure player for global mobility and others concerned about margin pressures and regulatory hurdles.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology Group is experiencing significant volatility as investors weigh robust quarterly results and a massive revenue surge against conservative forward guidance. While the community is actively debating whether the recent dip represents an overreaction by algorithms or legitimate valuation concerns, many are focusing on the company's long-term potential as a critical player in AI infrastructure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Karyopharm Therapeutics (KPTI) Stock Jumps 6.9%: Will It Continue to Soar?

Karyopharm Therapeutics (KPTI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Esperion Therapeutics (NASDAQ:ESPR) Share Price Crosses Below 200 Day Moving Average - Time to Sell?

Esperion Therapeutics (NASDAQ:ESPR) Stock Passes Below Two Hundred Day Moving Average - Here's Why...

Esperion Therapeutics (NASDAQ:ESPR) Insider Sells $15,411.60 in Stock

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) insider Benjamin Looker sold 5,708 shares of Esperion Therapeutics stock in a transaction dated Tuesday, March 17th. The shares were sold...

Insider Selling: Esperion Therapeutics (NASDAQ:ESPR) Insider Sells $15,411.60 in Stock

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) insider Benjamin Looker sold 5,708 shares of Esperion Therapeutics stock in a transaction dated Tuesday, March 17th. The stock was sold at...

Esperion Therapeutics (NASDAQ:ESPR) CFO Sells $17,409.04 in Stock

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) CFO Benjamin Halladay sold 6,424 shares of the company's stock in a transaction on Tuesday, March 17th. The stock was sold at an average...

Esperion Therapeutics (NASDAQ:ESPR) Stock Price Down 7.6% - Here's What Happened

Esperion Therapeutics (NASDAQ:ESPR) Stock Price Down 7.6% - Time to Sell...

Q1 EPS Estimate for Esperion Therapeutics Lowered by Analyst

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Free Report) - Investment analysts at HC Wainwright cut their Q1 2026 earnings per share estimates for Esperion Therapeutics in a research report issued on...

Esperion Therapeutics (NASDAQ:ESPR) Stock Price Up 7.8% Following Analyst Upgrade

Esperion Therapeutics (NASDAQ:ESPR) Shares Up 7.8% After Analyst Upgrade...

Esperion Therapeutics Touts 38% Revenue Growth, Corstasis Deal and 2026 Cash-Gen Path at Conference

Executives from Esperion Therapeutics (NASDAQ:ESPR) highlighted accelerating revenue growth, plans to expand its commercial footprint, and details of a pending acquisition during remarks at the...

Esperion Therapeutics (NASDAQ:ESPR) Upgraded to "Buy" at Wall Street Zen

Wall Street Zen upgraded Esperion Therapeutics from a "hold" rating to a "buy" rating in a research note on Saturday...

Esperion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.

Esperion Therapeutics Inc.

Peloswing

JFDI

ACInvestorBlog

GPaisa

A pillar of the Stocktwits ecosystem. This award recognizes the member who fosters connection, shares invaluable insights, and elevates the daily discussion to empower their fellow traders, on-platform.

ESPR
Esperion Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ESPR News

ESPREsperion Therapeutics Inc.